Delivery Order SPE2DB24D8002-SPE2DB24FJMSG

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYYM, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc. The $1,491.62 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. Dakota Drug, Inc. is a self-certified small disadvantaged business that operates as a for-profit subchapter S corporation. The company has significant experience providing...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYXJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,712.04 firm-fixed-price delivery order contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYUT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The $1,616.16 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The company has significant experience as a prime contractor to the DLA Troop Support...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZBS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 22, 2025. The contract has a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,250.46 firm fixed-price delivery order is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, valued at $2,477.84, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is structured as a firm fixed-price delivery order with a completion date of September 10, 2024. Dakota Drug, Inc. also holds a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,661.99 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This delivery order falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This federal contract award with ID SPE2DX15D8003|SPE2DX24F7B5P was issued by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,757.92 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not part of a set-aside program. The contract has an ultimate completion date of November 3, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,760.74 firm fixed-price contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a comprehensive range of...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMSG
    Delivery Order

The federal contract award SPE2DB24D8002|SPE2DB24FJMSG was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,386.01 firm fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. This contract award is associated with Dakota Drug, Inc.'s larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. The contract has an ultimate completion date of August 7, 2024. Dakota Drug, Inc.'s ability to secure this and other high-value DLA contracts demonstrates its important position in the agency's medical supply chain supporting U.S. Armed Forces operations.

Generated 11/5/24, 9:22 AM